Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CHOLIV L Syrup is a fixed-dose combination of tricholine citrate and sorbitol, developed and marketed by Caplet India. It is primarily indicated for the treatment of fatty liver disease, hepatotoxicity, and associated digestive disorders, as well as for the relief of occasional constipation. Tricholine citrate acts as a lipotropic and bile acid-binding agent that promotes fat metabolism in the liver, enhances bile secretion, and helps lower cholesterol levels. Sorbitol acts as an osmotic laxative that draws water into the large intestine, softening stools and promoting regular bowel movements. Together, these components support liver function, improve digestion, and maintain gastrointestinal health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tricholine citrate + sorbitol.